LifeStance Health announces 45‑million‑share secondary offering priced at $13.12 with concurrent 2‑million‑share buyback
LifeStance Health Group disclosed that existing shareholders will sell 45 million shares in a secondary public offering at $13.12 per share. The company will not receive any proceeds, but it has authorized a simultaneous repurchase of 2 million shares from the underwriters at the same price. The offering was priced on November 9, 2026, and the stock moved lower in pre‑market trading following the announcement.
Why it matters
The secondary offering adds 45 million shares to the market, increasing supply and potentially diluting existing shareholders' ownership, while the buyback of 2 million shares may offset some of that pressure. Investors should note the pricing at $13.12 per share and the lack of cash inflow to the company, which means the transaction does not improve LifeStance’s balance sheet.
Key facts
- 145 million shares are being sold in a secondary public offering. rttnews.com
- 2The offering price is $13.12 per share. seekingalpha.com
- 3The total value of the offering is $590.4 million. seekingalpha.com
- 4LifeStance authorized the repurchase of 2 million shares from the underwriters at the same price. rttnews.com
- 5Shares fell 6.32% in pre‑market trading after the announcement. rttnews.com
- 6The stock closed at $13.77 on Friday, November 6, 2026. rttnews.com
Summary written by AlphAI AI Desk from 7 of 7 sources. Not investment advice. Figures are as stated by the linked sources.